Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era.
about
MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemiaTargeting cancer with kinase inhibitorsThe incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML).
P2860
Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Changes in molecular biology o ...... tyrosine kinase inhibitor era.
@en
type
label
Changes in molecular biology o ...... tyrosine kinase inhibitor era.
@en
prefLabel
Changes in molecular biology o ...... tyrosine kinase inhibitor era.
@en
P2860
P1476
Changes in molecular biology o ...... tyrosine kinase inhibitor era.
@en
P2093
Guray Saydam
Melda Comert
P2860
P304
P50
P577
2013-08-19T00:00:00Z